Movement Disorders

 

If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu

 

Parkinson's Disease

COMIRB #	Title (Please click on the title to see approved advertisement)	Principal Investigator	Eligibility and Information	Advertisement
17-2318	A randomized, double blind, placebo-controlled parallel study of tolerability and efficacy of Cannabidiol (CBD) on motor symptoms in Parkinson’s disease	Leehey, Maureen A., MD	Clinical Trials	See Advertisement
16-2308	Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease	Isabelle Buard, PhD	Clinical Trials	See Advertisement
18-1356	Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential Tremor	Leehey, Maureen A., MD	N/A	N/A
18-0829	A Randomized, Placebo Surgery Controlled, Double-blinded, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Advanced Parkinson’s Disease with Motor Fluctuations	Kern, Drew, MD, MS	Clinical Trials	N/A
18-2047	A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 with Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease Patients	Fullard, Michelle, MD, MSCE	Clinical Trials	See Advertisement
19-0414	A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure	Hawkins, Trevor H., MD	Clinical Trials	N/A
19-0520	A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD˗9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure	Hawkins, Trevor H., MD	Clinical Trials	N/A
19-0478	A 14-Week, Double-Blind, Randomized, Three-Arm, Parallel Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease (gLIDe)	Hawkins, Trevor H., MD	Clinical Trials	See Advertisement
19-1405	Engaging the Denver Hispanic Community in Parkinson's Disease Research	Fullard, Michelle, MD, MSCE	N/A	See Advertisement
19-2471	Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease	Leehey, Maureen A., MD	Clinical Trials	N/A
19-0865	A Multi-center, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease (PD)	Berman, Brian D.,MD, MS	Clinical Trials	See Advertisement

 

Huntington's Disease

COMIRB #	Title (Please click on the title to see approved advertisement)	Principal Investigator	Eligibility and Information	Advertisement
16-2308	Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease and Other Basal Ganglia Disorders	Isabelle Buard, PhD	N/A	See Advertisement
18-0216	Perceived Palliative Care Needs in Huntington Disease	Brooke Heffernan, MD	N/A	See Advertisement
19-1840	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington Disease	Seeberger, Lauren C., MD	Clinical Trials	N/A

 

Dystonia

COMIRB #	Title (Please click on the title to see approved advertisement)	Principal Investigator	Eligibility and Information	Advertisement
17-1322	Transcranial electrical stimulation for the treatment of focal dystonia	Berman, Brian D., MD, MS	N/A	N/A
11-0647	Project 1: Natural History and Biospecimen Repository for Dystonia	Berman, Brian D., MD, MS	Clinical Trials	N/A

 

Ataxia

COMIRB #	Title (Please click on the title to see approved advertisement)	Principal Investigator	Eligibility and Information	Advertisement
18-0020	Clinical Trial Readiness for SCA1 and SCA3	Seeberger, Lauren C., MD	Clinical Trials	See Advertisement
18-1875	A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects with Spinocerebellar Ataxia	Seeberger, Lauren C., MD	Clinical Trials	See Advertisement
18-1641	Clinical Outcome Measures in Friedreich’s Ataxia	Seeberger, Lauren C., MD	Clinical Trials	N/A

 

Healthy Volunteer

COMIRB #	Title (Please click on the title to see approved advertisement)	Principal Investigator	Eligibility and Information	Advertisement
19-1251	Gamma band neural stimulation and its effects on resting state networks	Berman, Brian D., MD, MS	N/A	N/A
18-1356	Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential Tremor	Leehey, Maureen A., MD	N/A	N/A